Exploration of quantitative MRI-imaging for characterisation of pancreas carcinoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025747

Enrollment

Registered

2022-09-15

Start date

2022-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers C25.0

Interventions

Group 1: Healthy subjects in whom an initial test of the fingerprinting sequences is performed. In addition, the respiratory parameters, for example, are adjusted and optimized. Patients with pancreat

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers Patients diagnosed with pancreatic cancer

Exclusion criteria

Exclusion criteria: MRI contraindication

Design outcomes

Primary

Measure	Time frame
Differences in relaxation times between pancreas tissue and cancer.	—

Secondary

Measure	Time frame
Reduced image artifacts and faster acquisition.	—

Countries

Germany

Contacts

Public ContactGrischa Bratke

Institut für Diagnostische und Interventionelle Radiologie

grischa.bratke@uk-koeln.de022147882035

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026